Gerd Döring

20.5k total citations · 5 hit papers
176 papers, 14.4k citations indexed

About

Gerd Döring is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Gerd Döring has authored 176 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 72 papers in Molecular Biology and 28 papers in Molecular Medicine. Recurrent topics in Gerd Döring's work include Cystic Fibrosis Research Advances (86 papers), Bacterial biofilms and quorum sensing (60 papers) and Neonatal Respiratory Health Research (28 papers). Gerd Döring is often cited by papers focused on Cystic Fibrosis Research Advances (86 papers), Bacterial biofilms and quorum sensing (60 papers) and Neonatal Respiratory Health Research (28 papers). Gerd Döring collaborates with scholars based in Germany, United States and Italy. Gerd Döring's co-authors include Niels Høiby, Félix Ratjen, Martina Ulrich, K Botzenhart, Dieter Worlitzsch, Erich Gulbins, Harry Heijerman, Christiane Wolz, Joachim Riethmüller and Gerald B. Pier and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Gerd Döring

174 papers receiving 14.0k citations

Hit Papers

Therapy of CF-Patients with Amitriptyline and ... 2002 2026 2010 2018 2013 2002 2002 2003 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
    2013 1.2k citations Ute Graepler-Mainka, Andreas Hector et al. profile →
  2. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients
    2002 919 citations Dieter Worlitzsch, Robert Tarran et al. Journal of Clinical Investigation profile →
  3. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients
    2002 778 citations Dieter Worlitzsch, Robert Tarran et al. Journal of Clinical Investigation profile →
  4. Cystic fibrosis
    2003 699 citations Félix Ratjen, Gerd Döring profile →
  5. Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
    2012 365 citations Gerd Döring, Harry Heijerman et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Döring Germany 62 7.7k 6.4k 2.0k 1.8k 1.7k 176 14.4k
Jane L. Burns United States 61 7.8k 1.0× 5.8k 0.9× 3.4k 1.7× 2.3k 1.3× 932 0.5× 138 13.6k
Alice Prince United States 61 3.7k 0.5× 5.4k 0.8× 1.5k 0.8× 1.8k 1.0× 1.8k 1.1× 153 12.0k
David P. Speert Canada 60 5.0k 0.7× 7.4k 1.1× 2.5k 1.2× 1.9k 1.1× 1.1k 0.6× 183 14.7k
Bonnie W. Ramsey United States 71 16.5k 2.2× 5.5k 0.9× 2.5k 1.3× 3.5k 1.9× 1.2k 0.7× 199 21.6k
Helle Krogh Johansen Denmark 61 3.7k 0.5× 5.8k 0.9× 3.1k 1.6× 2.4k 1.3× 2.5k 1.5× 229 12.8k
Arnold L. Smith United States 60 5.9k 0.8× 2.9k 0.4× 1.9k 0.9× 4.2k 2.3× 1.1k 0.6× 306 13.9k
Burkhard Tümmler Germany 61 4.3k 0.6× 6.7k 1.0× 3.0k 1.5× 806 0.5× 548 0.3× 296 11.6k
Pradeep K. Singh United States 43 2.0k 0.3× 6.7k 1.0× 2.0k 1.0× 1.1k 0.6× 860 0.5× 67 11.2k
John R. W. Govan United Kingdom 52 5.0k 0.7× 4.0k 0.6× 1.6k 0.8× 1.1k 0.6× 317 0.2× 126 10.0k
Ronald L. Gibson United States 47 6.9k 0.9× 2.5k 0.4× 1.1k 0.6× 2.4k 1.3× 967 0.6× 130 9.8k

Countries citing papers authored by Gerd Döring

Since Specialization
Citations

This map shows the geographic impact of Gerd Döring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Döring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Döring more than expected).

Fields of papers citing papers by Gerd Döring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Döring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Döring. The network helps show where Gerd Döring may publish in the future.

Co-authorship network of co-authors of Gerd Döring

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Döring. A scholar is included among the top collaborators of Gerd Döring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Döring. Gerd Döring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hector, Andreas, Michael Kormann, Verónica Marcos, et al.. (2013). Expression and Regulation of Interferon-Related Development Regulator–1 in Cystic Fibrosis Neutrophils. American Journal of Respiratory Cell and Molecular Biology. 48(1). 71–77. 12 indexed citations
2.
Ulrich, Martina, Dieter Worlitzsch, Simona Viglio, et al.. (2010). Alveolar inflammation in cystic fibrosis. Journal of Cystic Fibrosis. 9(3). 217–227. 95 indexed citations
3.
Zhang, Yang, Xiang Li, Heike Grassmé, Gerd Döring, & Erich Gulbins. (2010). Alterations in Ceramide Concentration and pH Determine the Release of Reactive Oxygen Species by Cftr -Deficient Macrophages on Infection. The Journal of Immunology. 184(9). 5104–5111. 87 indexed citations
4.
Bragonzi, Alessandra, Moira Paroni, Alessandro Nonis, et al.. (2009). Pseudomonas aeruginosa Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence. American Journal of Respiratory and Critical Care Medicine. 180(2). 138–145. 204 indexed citations
5.
Kolpen, Mette, C.R. Hansen, Thomas Bjarnsholt, et al.. (2009). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax. 65(1). 57–62. 145 indexed citations
6.
Döring, Gerd, et al.. (2007). A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proceedings of the National Academy of Sciences. 104(26). 11020–11025. 135 indexed citations
7.
Döring, Gerd, J.S. Elborn, Marie Johannesson, et al.. (2007). Clinical trials in cystic fibrosis. Journal of Cystic Fibrosis. 6(2). 85–99. 36 indexed citations
8.
Campana, Silvia, Giovanni Taccetti, N. Ravenni, et al.. (2004). Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. Journal of Cystic Fibrosis. 3(3). 159–163. 51 indexed citations
9.
Paul, K., Ernst Rietschel, Manfred Ballmann, et al.. (2003). Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 169(6). 719–725. 139 indexed citations
10.
Jung, Andreas, A. Bauernfeind, Matthias Griese, et al.. (2002). Sequential genotyping ofPseudomonas aeruginosafrom upper and lower airways of cystic fibrosis patients. European Respiratory Journal. 20(6). 1457–1463. 45 indexed citations
11.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 778 indexed citations breakdown →
12.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 919 indexed citations breakdown →
13.
Horváth, Ildikó, William MacNee, Frank J. Kelly, et al.. (2001). “Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. European Respiratory Journal. 18(2). 420–430. 52 indexed citations
14.
Döring, Gerd, S.P. Conway, Harry Heijerman, et al.. (2000). Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. European Respiratory Journal. 16(4). 749–749. 463 indexed citations
15.
Viglio, Simona, Paolo Iadarola, Alessandro Lupi, et al.. (2000). MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. European Respiratory Journal. 15(6). 1039–1039. 87 indexed citations
16.
17.
Döring, Gerd. (1994). The Role of Neutrophil Elastase in Chronic Inflammation. American Journal of Respiratory and Critical Care Medicine. 150(6_Part_2). S114–S117. 226 indexed citations
18.
Steinkamp, Gratiana, Burkhard Tümmler, Monika Gappa, et al.. (1989). Long‐term tobramycin aerosol therapy in cystic fibrosis. Pediatric Pulmonology. 6(2). 91–98. 120 indexed citations
19.
Döring, Gerd, et al.. (1981). [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].. PubMed. 249(1). 89–98. 37 indexed citations
20.
Döring, Gerd, et al.. (1964). Die Sterilität der Frau : ein Leitfaden der Diagnostik und Therapie für die Praxis. Biblioteca Digital (Real Academia Nacional de Medicina). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane L. Burns Breakdown of academic impact, for papers by Alice Prince Breakdown of academic impact, for papers by David P. Speert Breakdown of academic impact, for papers by Bonnie W. Ramsey Breakdown of academic impact, for papers by Helle Krogh Johansen Breakdown of academic impact, for papers by Arnold L. Smith Breakdown of academic impact, for papers by Burkhard Tümmler Breakdown of academic impact, for papers by Pradeep K. Singh Breakdown of academic impact, for papers by John R. W. Govan Breakdown of academic impact, for papers by Ronald L. Gibson
Rankless by CCL
2026